Hyperliquid Strategies (NASDAQ:PURR - Get Free Report) had its target price upped by equities researchers at Cantor Fitzgerald from $22.60 to $34.20 in a note issued to investors on Thursday, Benzinga reports. The brokerage currently has an "overweight" rating on the stock. Cantor Fitzgerald's price target would indicate a potential upside of 184.29% from the stock's current price.
Other research analysts have also issued reports about the company. Wall Street Zen lowered Hyperliquid Strategies from a "hold" rating to a "sell" rating in a research report on Saturday, August 29th. Weiss Ratings raised Hyperliquid Strategies from a "sell (d+)" rating to a "hold (c)" rating in a research note on Friday, August 28th. Finally, Chardan Capital lifted their price objective on Hyperliquid Strategies from $9.75 to $17.00 and gave the stock a "buy" rating in a research note on Friday, August 28th. Three investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $20.40.
Check Out Our Latest Report on PURR
Hyperliquid Strategies Stock Performance
Shares of NASDAQ PURR opened at $12.03 on Thursday. The firm has a 50 day moving average price of $8.45 and a two-hundred day moving average price of $7.32. The stock has a market cap of $2.38 billion, a P/E ratio of -1.87 and a beta of 1.89. Hyperliquid Strategies has a 52-week low of $3.01 and a 52-week high of $14.14.
Institutional Inflows and Outflows
A number of institutional investors have recently modified their holdings of the stock. State of Wyoming bought a new position in Hyperliquid Strategies during the second quarter worth $46,000. Shepherd Financial Partners LLC bought a new stake in Hyperliquid Strategies in the second quarter valued at $79,000. Boothbay Fund Management LLC acquired a new position in shares of Hyperliquid Strategies during the fourth quarter valued at about $40,000. Lotus Technology Management LP acquired a new position in shares of Hyperliquid Strategies during the second quarter valued at about $93,000. Finally, XTX Topco Ltd bought a new position in shares of Hyperliquid Strategies during the 4th quarter worth about $48,000. Institutional investors and hedge funds own 9.45% of the company's stock.
About Hyperliquid Strategies
(
Get Free Report)
Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Hyperliquid Strategies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hyperliquid Strategies wasn't on the list.
While Hyperliquid Strategies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.